Northwire Canada EditionSaturday, July 11, 2026
Sign inSubscribe
Northwire
⌕
GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0%

Cannabis

Page 8
  1. May 21, 2026 · 08:45 · GTII · Routine +

    GTII Earnings Beat Masks Pricing Pressure as Shareholder Returns Accelerate

    Europe's Medical Marijuana Market Positioned for Explosive Multi-Billion Dollar Growth Through 2034

    01
  2. May 21, 2026 · 08:00 · DB · Routine +

    Decibel Cannabis Confirms Turnaround Trajectory with Q1 Revenue Surge, Yet FCF Drag Lingers

    Decibel Reports First Quarter 2026 Results: Quarterly Revenue Grows 41% YoY to $30 Million, Issues Q2 2026 Guidance

    02
  3. May 21, 2026 · 07:00 · VRNO · Neutral

    Verano Celebrates Vegas Milestone Amidst Regulatory Transition and Debt Restructuring

    Zen Leaf Dispensaries Mark 10-Year Las Vegas Anniversary with "All-in-at-10" Community-Focused Celebrations May 21st-May 30th

    03
  4. May 21, 2026 · 06:31 · VEXT · Routine +

    Vext Scales Ohio Operations While Tax Liabilities Loom Over Cash Position

    Vext Reports Q1 2026 Financial Results; Adjusted EBITDA up 73% Sequentially to $3.6 Million as Ohio Platform Scales

    04
  5. May 21, 2026 · 05:02 · HERB · Routine +

    Herbal Dispatch Exports Surge to 761kg in Week as European Strategy Validates, Yet Profitability Remains Elusive

    Herbal Dispatch Completes Export of 261kg of Medical Cannabis to Europe

    05
  6. May 20, 2026 · 08:15 · MDMA · Material +

    PharmAla’s ALA-002 draws a nine-figure pact with Nasdaq-listed Jupiter, signalling Big Pharma-style validation for next-gen MDMA in a transformed U.S. regulatory landscape.

    PharmAla Biotech Signs Term Sheet to License Exclusive U.S. Rights to ALA-002, Its Next-Generation MDMA Therapeutic, to Jupiter Neurosciences, Inc. (NASDAQ: JUNS) in a Transaction Valued at Over $100 Million

    06
  7. May 20, 2026 · 08:01 · OPTI · Material +

    Optimi Health’s psychedelic ambitions get a Nasdaq passport as a $15 million oversubscribed offering fuels US expansion bets.

    Optimi Health Announces Pricing of Oversubscribed US$15 Million Public Offering and Nasdaq Uplisting

    07
  8. May 20, 2026 · 07:38 · MDMA · Material +

    PharmAla’s $100M-Plus ALA-002 Licensing Pact with Nasdaq’s Jupiter Validates Next-Gen MDMA, Fueling a Pivotal Re-Rating

    Jupiter Neurosciences Secures $100M Term Sheet for Exclusive U.S. Rights to ALA-002, a Next-Generation MDMA Therapeutic from PharmAla Biotech

    08
  9. May 19, 2026 · 07:31 · NURL · Routine +

    Neural Therapeutics Retail Expansion Confirms Growth Trajectory Ahead of Critical M&A Vote

    Neural Portfolio Company Hanf.com Expands German Retail Footprint with New Muhldorf am Inn Store and Four Refurbished Locations

    09
  10. May 19, 2026 · 07:31 · PCLO · Routine −

    PharmaCielo Settles Debt Interest with Equity Amidst Liquidity Concerns

    PharmaCielo Announces the Issuance of Interest Shares and Update on Insider Bridge Financing

    10
  11. May 19, 2026 · 06:30 · PLTH · Routine +

    Florida Infrastructure Milestone Fails to Offset Q1 Earnings Deterioration and Cash Burn Concerns

    Planet 13 Receives OMMU Approval for Florida BHO Extraction Facility

    11
  12. May 19, 2026 · 05:02 · HERB · Routine +

    Herbal Dispatch Scales European Exports as Domestic Earnings Turnaround Validates Growth Thesis

    Herbal Dispatch Completes Company Record 500kg Medical Cannabis Export Shipment to Europe

    12
  13. May 15, 2026 · 17:00 · WEED · Routine −

    Canopy Growth’s accounting stumble is a self-inflicted wound that muddies the recovery narrative just as operational momentum was building.

    Canopy Growth Provides Update on Financial Reporting and Announces Fourth Quarter and Fiscal Year 2026 Financial Results to be Presented on June 15, 2026

    13
  14. May 14, 2026 · 08:45 · WEED · Routine +

    Canopy Growth’s latest product tweak gets swept into a wider European boom story, but the stock’s rebound remains more about survival than fireworks.

    Europe's Cannabis Boom Is Accelerating as Billions Flow into Licensed Markets

    14
← Newer Older →